Regeneron Pharmaceuticals Inc. buy Sanford C. Bernstein
Summary
This prediction ended on 13.03.25 with a price of €633.80. The prediction for Regeneron Pharmaceuticals Inc. disappointed with a performance of -28.55%. Sanford_C__Bernstein has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. A total of €0.84 was paid as dividends for this prediction. Sanford_C__Bernstein has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.820% | 3.820% | 13.979% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Sanford_C__Bernstein for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.
Current prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
27.08.25
27.08.26
01.04.26
Stopped prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
07.01.25
07.01.26
08.01.26

